Australia's most trusted
source of pharma news
Thursday, 04 September 2025
Posted 2 September 2025 PM
Bayer has paused its membership with Medicines Australia as it experiments with a new engagement model to see if it can achieve greater impact through "more targeted, impact-driven partnerships".
The pause came into effect in July this year with Bayer stating it believes in the power and importance of local industry to drive meaningful policy change.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.